Annual CFI
$20.21 M
+$1.23 B+101.67%
31 December 2023
Summary:
Bio-Rad Laboratories annual cash flow from investing activities is currently $20.21 million, with the most recent change of +$1.23 billion (+101.67%) on 31 December 2023. During the last 3 years, it has risen by +$90.10 million (+128.91%). BIO annual CFI is now at all-time high.BIO Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
-$55.64 M
-$24.71 M-79.89%
30 September 2024
Summary:
Bio-Rad Laboratories quarterly cash flow from investing activities is currently -$55.64 million, with the most recent change of -$24.71 million (-79.89%) on 30 September 2024. Over the past year, it has dropped by -$46.14 million (-485.64%). BIO quarterly CFI is now -131.60% below its all-time high of $176.04 million, reached on 30 September 2007.BIO Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
-$57.46 M
-$46.14 M-407.45%
30 September 2024
Summary:
Bio-Rad Laboratories TTM cash flow from investing activities is currently -$57.46 million, with the most recent change of -$46.14 million (-407.45%) on 30 September 2024. Over the past year, it has increased by +$53.08 million (+48.02%). BIO TTM CFI is now -178.04% below its all-time high of $73.63 million, reached on 31 March 2014.BIO TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BIO Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +101.7% | -485.6% | +48.0% |
| 3 y3 years | +128.9% | +31.6% | +80.2% |
| 5 y5 years | +110.8% | +49.4% | +71.6% |
BIO Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +101.7% | -177.1% | +93.9% | -220.7% | +96.7% |
| 5 y | 5 years | at high | +101.7% | -161.2% | +93.9% | -220.7% | +96.7% |
| alltime | all time | at high | +101.7% | -131.6% | +93.9% | -178.0% | +96.7% |
Bio-Rad Laboratories Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$55.64 M(+79.9%) | -$57.46 M(+407.5%) |
| June 2024 | - | -$30.93 M(-28.2%) | -$11.32 M(-123.8%) |
| Mar 2024 | - | -$43.09 M(-159.7%) | $47.59 M(+135.5%) |
| Dec 2023 | $20.21 M(-101.7%) | $72.20 M(-860.0%) | $20.21 M(-118.3%) |
| Sept 2023 | - | -$9.50 M(-133.9%) | -$110.54 M(-41.7%) |
| June 2023 | - | $27.98 M(-139.7%) | -$189.46 M(-47.7%) |
| Mar 2023 | - | -$70.47 M(+20.4%) | -$361.93 M(-70.0%) |
| Dec 2022 | -$1.21 B(+51.4%) | -$58.55 M(-33.8%) | -$1.21 B(-29.6%) |
| Sept 2022 | - | -$88.42 M(-38.8%) | -$1.72 B(+0.4%) |
| June 2022 | - | -$144.48 M(-84.2%) | -$1.71 B(+2.7%) |
| Mar 2022 | - | -$916.14 M(+61.5%) | -$1.67 B(+108.8%) |
| Dec 2021 | -$797.38 M(+1040.8%) | -$567.43 M(+597.5%) | -$797.38 M(+175.2%) |
| Sept 2021 | - | -$81.35 M(-18.9%) | -$289.71 M(+146.6%) |
| June 2021 | - | -$100.28 M(+107.5%) | -$117.50 M(+11.1%) |
| Mar 2021 | - | -$48.33 M(-19.1%) | -$105.80 M(+51.4%) |
| Dec 2020 | -$69.89 M(-66.5%) | -$59.75 M(-165.8%) | -$69.89 M(-2.0%) |
| Sept 2020 | - | $90.85 M(-202.6%) | -$71.34 M(-73.8%) |
| June 2020 | - | -$88.57 M(+613.0%) | -$272.10 M(+37.0%) |
| Mar 2020 | - | -$12.42 M(-79.7%) | -$198.60 M(-4.9%) |
| Dec 2019 | -$208.89 M(+11.7%) | -$61.20 M(-44.3%) | -$208.89 M(+3.2%) |
| Sept 2019 | - | -$109.91 M(+629.3%) | -$202.50 M(+65.8%) |
| June 2019 | - | -$15.07 M(-33.6%) | -$122.10 M(-36.0%) |
| Mar 2019 | - | -$22.71 M(-58.6%) | -$190.88 M(+2.1%) |
| Dec 2018 | -$186.98 M(+6.5%) | -$54.81 M(+85.7%) | -$186.98 M(+28.7%) |
| Sept 2018 | - | -$29.51 M(-64.8%) | -$145.25 M(+11.3%) |
| June 2018 | - | -$83.84 M(+345.6%) | -$130.56 M(+55.4%) |
| Mar 2018 | - | -$18.82 M(+43.8%) | -$84.00 M(-52.2%) |
| Dec 2017 | -$175.57 M(-17.9%) | -$13.08 M(-11.7%) | -$175.57 M(-17.4%) |
| Sept 2017 | - | -$14.81 M(-60.3%) | -$212.61 M(-15.4%) |
| June 2017 | - | -$37.28 M(-66.2%) | -$251.23 M(-8.1%) |
| Mar 2017 | - | -$110.39 M(+120.2%) | -$273.41 M(+27.8%) |
| Dec 2016 | -$213.88 M(+28.2%) | -$50.12 M(-6.2%) | -$213.88 M(-13.6%) |
| Sept 2016 | - | -$53.43 M(-10.2%) | -$247.53 M(+11.8%) |
| June 2016 | - | -$59.47 M(+16.9%) | -$221.34 M(+16.7%) |
| Mar 2016 | - | -$50.86 M(-39.3%) | -$189.74 M(+13.7%) |
| Dec 2015 | -$166.87 M(-12.4%) | -$83.78 M(+207.6%) | -$166.87 M(+25.9%) |
| Sept 2015 | - | -$27.23 M(-2.3%) | -$132.53 M(-12.7%) |
| June 2015 | - | -$27.86 M(-0.5%) | -$151.81 M(-17.0%) |
| Mar 2015 | - | -$27.99 M(-43.4%) | -$182.93 M(-4.0%) |
| Dec 2014 | -$190.51 M(<-9900.0%) | -$49.44 M(+6.3%) | -$190.51 M(+5.5%) |
| Sept 2014 | - | -$46.51 M(-21.1%) | -$180.51 M(-541.0%) |
| June 2014 | - | -$58.99 M(+65.8%) | $40.93 M(-44.4%) |
| Mar 2014 | - | -$35.57 M(-9.8%) | $73.63 M(+7912.1%) |
| Dec 2013 | $919.00 K(-100.2%) | -$39.45 M(-122.5%) | $919.00 K(-104.8%) |
| Sept 2013 | - | $174.93 M(-765.5%) | -$19.26 M(-93.5%) |
| June 2013 | - | -$26.28 M(-75.7%) | -$298.11 M(-29.4%) |
| Mar 2013 | - | -$108.28 M(+81.6%) | -$422.38 M(+5.5%) |
| Dec 2012 | -$400.39 M(+3.6%) | -$59.62 M(-42.6%) | -$400.39 M(-22.0%) |
| Sept 2012 | - | -$103.93 M(-31.0%) | -$513.21 M(+10.3%) |
| June 2012 | - | -$150.55 M(+74.5%) | -$465.09 M(+17.6%) |
| Mar 2012 | - | -$86.28 M(-50.0%) | -$395.32 M(+2.3%) |
| Dec 2011 | -$386.33 M(+78.4%) | -$172.44 M(+209.0%) | -$386.33 M(+45.2%) |
| Sept 2011 | - | -$55.81 M(-30.9%) | -$265.99 M(-2.0%) |
| June 2011 | - | -$80.78 M(+4.5%) | -$271.44 M(+25.2%) |
| Mar 2011 | - | -$77.29 M(+48.3%) | -$216.79 M(+0.1%) |
| Dec 2010 | -$216.51 M(+23.1%) | -$52.10 M(-15.0%) | -$216.51 M(+15.8%) |
| Sept 2010 | - | -$61.26 M(+134.4%) | -$187.00 M(-10.2%) |
| June 2010 | - | -$26.14 M(-66.1%) | -$208.33 M(-13.3%) |
| Mar 2010 | - | -$77.01 M(+240.9%) | -$240.25 M(+36.5%) |
| Dec 2009 | -$175.95 M(+20.4%) | -$22.59 M(-72.6%) | -$175.95 M(-19.1%) |
| Sept 2009 | - | -$82.59 M(+42.3%) | -$217.60 M(+32.1%) |
| June 2009 | - | -$58.05 M(+356.5%) | -$164.72 M(+33.0%) |
| Mar 2009 | - | -$12.72 M(-80.2%) | -$123.86 M(-15.2%) |
| Dec 2008 | -$146.11 M(-42.6%) | -$64.24 M(+116.2%) | -$146.11 M(-69.3%) |
| Sept 2008 | - | -$29.71 M(+72.9%) | -$476.36 M(+76.0%) |
| June 2008 | - | -$17.19 M(-50.8%) | -$270.60 M(-10.2%) |
| Mar 2008 | - | -$34.96 M(-91.1%) | -$301.25 M(+18.4%) |
| Dec 2007 | -$254.43 M | -$394.49 M(-324.1%) | -$254.43 M(-483.4%) |
| Sept 2007 | - | $176.04 M(-468.0%) | $66.35 M(-138.6%) |
| June 2007 | - | -$47.84 M(-503.4%) | -$171.97 M(-15.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2007 | - | $11.86 M(-116.1%) | -$204.13 M(-1.7%) |
| Dec 2006 | -$207.75 M(+3266.0%) | -$73.70 M(+18.3%) | -$207.75 M(+65.0%) |
| Sept 2006 | - | -$62.29 M(-22.1%) | -$125.92 M(+24.8%) |
| June 2006 | - | -$79.99 M(-1071.1%) | -$100.92 M(+9.9%) |
| Mar 2006 | - | $8.24 M(+1.4%) | -$91.82 M(+1387.7%) |
| Dec 2005 | -$6.17 M(-96.7%) | $8.12 M(-121.8%) | -$6.17 M(-95.4%) |
| Sept 2005 | - | -$37.29 M(-47.4%) | -$135.39 M(+14.8%) |
| June 2005 | - | -$70.89 M(-175.5%) | -$117.89 M(+183.3%) |
| Mar 2005 | - | $93.89 M(-177.5%) | -$41.61 M(-77.7%) |
| Dec 2004 | -$186.32 M(-2.1%) | -$121.10 M(+512.0%) | -$186.32 M(+5.0%) |
| Sept 2004 | - | -$19.79 M(-467.3%) | -$177.45 M(-9.2%) |
| June 2004 | - | $5.39 M(-110.6%) | -$195.40 M(-11.3%) |
| Mar 2004 | - | -$50.82 M(-54.7%) | -$220.34 M(+15.8%) |
| Dec 2003 | -$190.24 M(+249.3%) | -$112.23 M(+197.4%) | -$190.24 M(+109.8%) |
| Sept 2003 | - | -$37.73 M(+93.0%) | -$90.69 M(+37.6%) |
| June 2003 | - | -$19.55 M(-5.7%) | -$65.93 M(-1.0%) |
| Mar 2003 | - | -$20.73 M(+63.4%) | -$66.60 M(+22.3%) |
| Dec 2002 | -$54.46 M(+14.6%) | -$12.68 M(-2.3%) | -$54.46 M(+2.8%) |
| Sept 2002 | - | -$12.97 M(-35.8%) | -$52.99 M(-8.6%) |
| June 2002 | - | -$20.21 M(+135.5%) | -$57.96 M(+20.8%) |
| Mar 2002 | - | -$8.58 M(-23.5%) | -$47.96 M(+0.9%) |
| Dec 2001 | -$47.54 M(-611.4%) | -$11.22 M(-37.5%) | -$47.54 M(+31.6%) |
| Sept 2001 | - | -$17.94 M(+75.6%) | -$36.13 M(-937.9%) |
| June 2001 | - | -$10.22 M(+25.2%) | $4.31 M(-38.6%) |
| Mar 2001 | - | -$8.16 M(-4440.4%) | $7.02 M(-24.5%) |
| Dec 2000 | $9.30 M(-104.2%) | $188.00 K(-99.2%) | $9.30 M(-104.6%) |
| Sept 2000 | - | $22.50 M(-399.6%) | -$202.09 M(-11.2%) |
| June 2000 | - | -$7.51 M(+27.6%) | -$227.59 M(+0.7%) |
| Mar 2000 | - | -$5.88 M(-97.2%) | -$225.98 M(+1.2%) |
| Dec 1999 | -$223.30 M(+782.6%) | -$211.20 M(+6940.0%) | -$223.30 M(+1081.5%) |
| Sept 1999 | - | -$3.00 M(-49.2%) | -$18.90 M(+0.5%) |
| June 1999 | - | -$5.90 M(+84.4%) | -$18.80 M(-17.9%) |
| Mar 1999 | - | -$3.20 M(-52.9%) | -$22.90 M(-9.5%) |
| Dec 1998 | -$25.30 M(-54.7%) | -$6.80 M(+134.5%) | -$25.30 M(-55.2%) |
| Sept 1998 | - | -$2.90 M(-71.0%) | -$56.50 M(-10.6%) |
| June 1998 | - | -$10.00 M(+78.6%) | -$63.20 M(+10.1%) |
| Mar 1998 | - | -$5.60 M(-85.3%) | -$57.40 M(+2.7%) |
| Dec 1997 | -$55.90 M(+277.7%) | -$38.00 M(+295.8%) | -$55.90 M(+131.0%) |
| Sept 1997 | - | -$9.60 M(+128.6%) | -$24.20 M(+33.0%) |
| June 1997 | - | -$4.20 M(+2.4%) | -$18.20 M(+6.4%) |
| Mar 1997 | - | -$4.10 M(-34.9%) | -$17.10 M(+15.5%) |
| Dec 1996 | -$14.80 M(+6.5%) | -$6.30 M(+75.0%) | -$14.80 M(+23.3%) |
| Sept 1996 | - | -$3.60 M(+16.1%) | -$12.00 M(+17.6%) |
| June 1996 | - | -$3.10 M(+72.2%) | -$10.20 M(-19.0%) |
| Mar 1996 | - | -$1.80 M(-48.6%) | -$12.60 M(-9.4%) |
| Dec 1995 | -$13.90 M(+6.1%) | -$3.50 M(+94.4%) | -$13.90 M(-4.1%) |
| Sept 1995 | - | -$1.80 M(-67.3%) | -$14.50 M(-10.5%) |
| June 1995 | - | -$5.50 M(+77.4%) | -$16.20 M(+14.1%) |
| Mar 1995 | - | -$3.10 M(-24.4%) | -$14.20 M(+8.4%) |
| Dec 1994 | -$13.10 M(+48.9%) | -$4.10 M(+17.1%) | -$13.10 M(+15.9%) |
| Sept 1994 | - | -$3.50 M(0.0%) | -$11.30 M(+34.5%) |
| June 1994 | - | -$3.50 M(+75.0%) | -$8.40 M(-28.2%) |
| Mar 1994 | - | -$2.00 M(-13.0%) | -$11.70 M(+33.0%) |
| Dec 1993 | -$8.80 M(-27.3%) | -$2.30 M(+283.3%) | -$8.80 M(+23.9%) |
| Sept 1993 | - | -$600.00 K(-91.2%) | -$7.10 M(-19.3%) |
| June 1993 | - | -$6.80 M(-855.6%) | -$8.80 M(-3.3%) |
| Mar 1993 | - | $900.00 K(-250.0%) | -$9.10 M(-24.8%) |
| Dec 1992 | -$12.10 M(-54.5%) | -$600.00 K(-73.9%) | -$12.10 M(-31.3%) |
| Sept 1992 | - | -$2.30 M(-67.6%) | -$17.60 M(-26.4%) |
| June 1992 | - | -$7.10 M(+238.1%) | -$23.90 M(+2.1%) |
| Mar 1992 | - | -$2.10 M(-65.6%) | -$23.40 M(-12.0%) |
| Dec 1991 | -$26.60 M(+51.1%) | -$6.10 M(-29.1%) | -$26.60 M(-2.9%) |
| Sept 1991 | - | -$8.60 M(+30.3%) | -$27.40 M(+20.2%) |
| June 1991 | - | -$6.60 M(+24.5%) | -$22.80 M(+16.3%) |
| Mar 1991 | - | -$5.30 M(-23.2%) | -$19.60 M(+11.4%) |
| Dec 1990 | -$17.60 M(+4.8%) | -$6.90 M(+72.5%) | -$17.60 M(+64.5%) |
| Sept 1990 | - | -$4.00 M(+17.6%) | -$10.70 M(+59.7%) |
| June 1990 | - | -$3.40 M(+3.0%) | -$6.70 M(+103.0%) |
| Mar 1990 | - | -$3.30 M | -$3.30 M |
| Dec 1989 | -$16.80 M | - | - |
FAQ
- What is Bio-Rad Laboratories annual cash flow from investing activities?
- What is the all time high annual CFI for Bio-Rad Laboratories?
- What is Bio-Rad Laboratories annual CFI year-on-year change?
- What is Bio-Rad Laboratories quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Bio-Rad Laboratories?
- What is Bio-Rad Laboratories quarterly CFI year-on-year change?
- What is Bio-Rad Laboratories TTM cash flow from investing activities?
- What is the all time high TTM CFI for Bio-Rad Laboratories?
- What is Bio-Rad Laboratories TTM CFI year-on-year change?
What is Bio-Rad Laboratories annual cash flow from investing activities?
The current annual CFI of BIO is $20.21 M
What is the all time high annual CFI for Bio-Rad Laboratories?
Bio-Rad Laboratories all-time high annual cash flow from investing activities is $20.21 M
What is Bio-Rad Laboratories annual CFI year-on-year change?
Over the past year, BIO annual cash flow from investing activities has changed by +$1.23 B (+101.67%)
What is Bio-Rad Laboratories quarterly cash flow from investing activities?
The current quarterly CFI of BIO is -$55.64 M
What is the all time high quarterly CFI for Bio-Rad Laboratories?
Bio-Rad Laboratories all-time high quarterly cash flow from investing activities is $176.04 M
What is Bio-Rad Laboratories quarterly CFI year-on-year change?
Over the past year, BIO quarterly cash flow from investing activities has changed by -$46.14 M (-485.64%)
What is Bio-Rad Laboratories TTM cash flow from investing activities?
The current TTM CFI of BIO is -$57.46 M
What is the all time high TTM CFI for Bio-Rad Laboratories?
Bio-Rad Laboratories all-time high TTM cash flow from investing activities is $73.63 M
What is Bio-Rad Laboratories TTM CFI year-on-year change?
Over the past year, BIO TTM cash flow from investing activities has changed by +$53.08 M (+48.02%)